1. Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
2. Department of Hematologic Malignancies, Levine Cancer Institute/Atrium Health, Charlotte, NC, USA;
3. Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
4. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA